245 related articles for article (PubMed ID: 20417880)
1. Simvastatin promotes osteoblast viability and differentiation via Ras/Smad/Erk/BMP-2 signaling pathway.
Chen PY; Sun JS; Tsuang YH; Chen MH; Weng PW; Lin FH
Nutr Res; 2010 Mar; 30(3):191-9. PubMed ID: 20417880
[TBL] [Abstract][Full Text] [Related]
2. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
[TBL] [Abstract][Full Text] [Related]
3. Induction of osteoblast differentiation indices by statins in MC3T3-E1 cells.
Maeda T; Matsunuma A; Kurahashi I; Yanagawa T; Yoshida H; Horiuchi N
J Cell Biochem; 2004 Jun; 92(3):458-71. PubMed ID: 15156558
[TBL] [Abstract][Full Text] [Related]
4. Syringetin, a flavonoid derivative in grape and wine, induces human osteoblast differentiation through bone morphogenetic protein-2/extracellular signal-regulated kinase 1/2 pathway.
Hsu YL; Liang HL; Hung CH; Kuo PL
Mol Nutr Food Res; 2009 Nov; 53(11):1452-61. PubMed ID: 19784998
[TBL] [Abstract][Full Text] [Related]
5. Osthole-mediated cell differentiation through bone morphogenetic protein-2/p38 and extracellular signal-regulated kinase 1/2 pathway in human osteoblast cells.
Kuo PL; Hsu YL; Chang CH; Chang JK
J Pharmacol Exp Ther; 2005 Sep; 314(3):1290-9. PubMed ID: 15956019
[TBL] [Abstract][Full Text] [Related]
6. Simvastatin inhibits osteoclast differentiation induced by bone morphogenetic protein-2 and RANKL through regulating MAPK, AKT and Src signaling.
Yamashita M; Otsuka F; Mukai T; Yamanaka R; Otani H; Matsumoto Y; Nakamura E; Takano M; Sada KE; Makino H
Regul Pept; 2010 Jun; 162(1-3):99-108. PubMed ID: 20346376
[TBL] [Abstract][Full Text] [Related]
7. Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells.
Xiao G; Gopalakrishnan R; Jiang D; Reith E; Benson MD; Franceschi RT
J Bone Miner Res; 2002 Jan; 17(1):101-10. PubMed ID: 11771655
[TBL] [Abstract][Full Text] [Related]
8. Simvastatin promotes osteoblast differentiation and mineralization in MC3T3-E1 cells.
Maeda T; Matsunuma A; Kawane T; Horiuchi N
Biochem Biophys Res Commun; 2001 Jan; 280(3):874-7. PubMed ID: 11162604
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of bone morphogenetic protein-2 expression and bone formation by coumarin derivatives via p38 and ERK-dependent pathway in osteoblasts.
Tang CH; Yang RS; Chien MY; Chen CC; Fu WM
Eur J Pharmacol; 2008 Jan; 579(1-3):40-9. PubMed ID: 17980360
[TBL] [Abstract][Full Text] [Related]
10. Involvement of ERK in BMP-2 induced osteoblastic differentiation of mesenchymal progenitor cell line C3H10T1/2.
Lou J; Tu Y; Li S; Manske PR
Biochem Biophys Res Commun; 2000 Feb; 268(3):757-62. PubMed ID: 10679278
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor activity is involved in the osteoblastic differentiation regulated by bone morphogenetic proteins and tumor necrosis factor-α.
Takano M; Otsuka F; Matsumoto Y; Inagaki K; Takeda M; Nakamura E; Tsukamoto N; Miyoshi T; Sada KE; Makino H
Mol Cell Endocrinol; 2012 Jan; 348(1):224-32. PubMed ID: 21888945
[TBL] [Abstract][Full Text] [Related]
12. Low-level laser irradiation enhances BMP-induced osteoblast differentiation by stimulating the BMP/Smad signaling pathway.
Hirata S; Kitamura C; Fukushima H; Nakamichi I; Abiko Y; Terashita M; Jimi E
J Cell Biochem; 2010 Dec; 111(6):1445-52. PubMed ID: 20830741
[TBL] [Abstract][Full Text] [Related]
13. Smad1 and smad5 act downstream of intracellular signalings of BMP-2 that inhibits myogenic differentiation and induces osteoblast differentiation in C2C12 myoblasts.
Yamamoto N; Akiyama S; Katagiri T; Namiki M; Kurokawa T; Suda T
Biochem Biophys Res Commun; 1997 Sep; 238(2):574-80. PubMed ID: 9299554
[TBL] [Abstract][Full Text] [Related]
14. Lactone form 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins) stimulate the osteoblastic differentiation of mouse periodontal ligament cells via the ERK pathway.
Kim IS; Jeong BC; Kim OS; Kim YJ; Lee SE; Lee KN; Koh JT; Chung HJ
J Periodontal Res; 2011 Apr; 46(2):204-13. PubMed ID: 21198644
[TBL] [Abstract][Full Text] [Related]
15. RhoA GTPase inactivation by statins induces osteosarcoma cell apoptosis by inhibiting p42/p44-MAPKs-Bcl-2 signaling independently of BMP-2 and cell differentiation.
Fromigué O; Haÿ E; Modrowski D; Bouvet S; Jacquel A; Auberger P; Marie PJ
Cell Death Differ; 2006 Nov; 13(11):1845-56. PubMed ID: 16470222
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase inhibitors promote osteoblast maturation.
Schroeder TM; Westendorf JJ
J Bone Miner Res; 2005 Dec; 20(12):2254-63. PubMed ID: 16294278
[TBL] [Abstract][Full Text] [Related]
17. Osteoactivin acts as downstream mediator of BMP-2 effects on osteoblast function.
Abdelmagid SM; Barbe MF; Arango-Hisijara I; Owen TA; Popoff SN; Safadi FF
J Cell Physiol; 2007 Jan; 210(1):26-37. PubMed ID: 17034042
[TBL] [Abstract][Full Text] [Related]
18. Simvastatin and atorvastatin enhance gene expression of collagen type 1 and osteocalcin in primary human osteoblasts and MG-63 cultures.
Ruiz-Gaspa S; Nogues X; Enjuanes A; Monllau JC; Blanch J; Carreras R; Mellibovsky L; Grinberg D; Balcells S; Díez-Perez A; Pedro-Botet J
J Cell Biochem; 2007 Aug; 101(6):1430-8. PubMed ID: 17252541
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase C-dependent upregulation of N-cadherin expression by phorbol ester in human calvaria osteoblasts.
Delannoy P; Lemonnier J; Haÿ E; Modrowski D; Marie PJ
Exp Cell Res; 2001 Sep; 269(1):154-61. PubMed ID: 11525648
[TBL] [Abstract][Full Text] [Related]
20. Astragaloside II induces osteogenic activities of osteoblasts through the bone morphogenetic protein-2/MAPK and Smad1/5/8 pathways.
Kong XH; Niu YB; Song XM; Zhao DD; Wang J; Wu XL; Zhang R; Mei QB
Int J Mol Med; 2012 Jun; 29(6):1090-8. PubMed ID: 22426655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
